Navigation Links
High development costs hinder entry of cancer super drugs into the market

Cancer patients in the future could benefit from pharmacogenomics or the field of personalized medicine where therapies could be tailored to suit individual patients. Few drugs which target specific protein receptors in cancer are already in the market and the decoding of the human genome// offers great promise to patients, as the therapy could become more specialized. However, all this comes with a heavy cost and cancer research experts warn that such breakthroughs may not lead to new treatment due to the cost.

Pharmaceutical companies face formidable problems in this new treatment approach as it costs about $100 million to develop a cancer drug and only about one in ten make it to the market. The developmental costs of these drugs are so high because they are targeted at specific molecules and this requires sophisticated screening tests.

The pharma companies are already pulling out of oncology drugs since the potential market is too small, as the patients treated with a particular drug are confined to a small genetically defined subgroup, and the sales from this small group would not cover the development costs. Unless scientists are able to show that these drugs work on a specific genetic type instead of on only 2 or 3 per cent of patients, these drugs may not make it to the market.

A cancer research expert, Dr. Keith Snell warned that if development costs are not reduced, the new cancer therapies have very slim chances of reaching the cancer patients. He however suggested that the solution lies in simplifying clinical trials and small biotechnology companies, major drug companies and scientific researchers agreeing to share the risks, thereby making the development process a more economic proposition.


Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Role of zinc in development
3. Particulate matter affects lung development
4. Fossil teeth and human development
5. Fireflies help speed development of new drugs
6. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
7. New fertility drug development techniques by Organon
8. Biosensor chip to help drug development
9. Cells critical for asthma development found
10. ICMR along with other International Research organisation with drug development for Neglected Diseases
11. Epilepsy surgery to help child development
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson ... offers insurance and financial preparation services, is providing an update on a charitable ... , Rock City Rescue is a locally recognized nonprofit that provides shelter and ...
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: